NYSE American - Delayed Quote USD

CEL-SCI Corporation (CVM)

0.2468
-0.0080
(-3.14%)
At close: May 9 at 4:00:00 PM EDT
0.2504
+0.00
+(1.46%)
After hours: May 9 at 7:56:41 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
26,760.0050
26,352.4740
31,476.0740
36,062.7930
36,194.1290
Operating Income
-26,760.0050
-26,352.4740
-31,476.0740
-36,062.7930
-36,194.1290
Net Non Operating Interest Income Expense
-718.0800
-745.6730
-675.4160
-1,081.0340
-1,149.2880
Other Income Expense
194.0820
177.6820
-42.8130
443.1460
982.3080
Pretax Income
-27,284.0030
-26,920.4650
-32,194.3030
-36,700.6810
-36,361.1090
Net Income Common Stockholders
-27,943.4590
-27,579.9210
-32,365.8550
-37,629.8030
-36,711.9700
Average Dilution Earnings
--
--
--
0
-1,085.5400
Diluted NI Available to Com Stockholders
-27,943.4590
-27,579.9210
-32,365.8550
-37,629.8030
-37,797.5100
Basic EPS
-0.48
-0.51
-0.73
-0.87
-0.90
Diluted EPS
-0.48
-0.51
-0.73
-0.87
-0.90
Basic Average Shares
58,258.8030
54,044.9890
44,479.8650
43,148.8880
40,662.1370
Diluted Average Shares
58,258.8030
54,044.9890
44,479.8650
43,148.8880
40,694.2480
Total Operating Income as Reported
-26,760.0050
-26,352.4740
-31,476.0740
-36,062.7930
-36,194.1290
Total Expenses
26,760.0050
26,352.4740
31,476.0740
36,062.7930
36,194.1290
Net Income from Continuing & Discontinued Operation
-27,284.0030
-26,920.4650
-32,194.3030
-36,700.6810
-36,361.1090
Normalized Income
-27,284.0030
-26,920.4650
-32,194.3030
-37,067.4720
-37,351.6300
Interest Expense
718.0800
745.6730
675.4160
1,081.0340
1,149.2880
Net Interest Income
-718.0800
-745.6730
-675.4160
-1,081.0340
-1,149.2880
EBIT
-26,565.9230
-26,174.7920
-31,518.8870
-35,619.6470
-35,211.8210
EBITDA
-22,606.1810
-22,205.6090
-27,560.5530
-31,790.7300
-32,980.7130
Reconciled Depreciation
3,959.7420
3,969.1830
3,958.3340
3,828.9170
2,231.1080
Net Income from Continuing Operation Net Minority Interest
-27,284.0030
-26,920.4650
-32,194.3030
-36,700.6810
-36,361.1090
Total Unusual Items Excluding Goodwill
--
--
--
366.7910
990.5210
Total Unusual Items
--
--
--
366.7910
990.5210
Normalized EBITDA
-22,606.1810
-22,205.6090
-27,560.5530
-32,157.5210
-33,971.2340
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
9/30/2021 - 12/8/1983

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CYCC Cyclacel Pharmaceuticals, Inc.
0.2534
-15.53%
 
NWBO Northwest Biotherapeutics, Inc.
0.2800
+1.08%
 
CANF Can-Fite BioPharma Ltd.
1.1100
-0.45%
 
INAB IN8bio, Inc.
0.1574
-6.25%
 
CRIS Curis, Inc.
1.8900
-10.00%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
 
CTXR Citius Pharmaceuticals, Inc.
0.7500
+7.30%
 
SPRB Spruce Biosciences, Inc.
0.0715
+2.14%
 
ADTX Aditxt, Inc.
1.7300
+1.76%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.7010
+1.73%